ME/CFS with MCAS and dysautonomia, uses wheelchair, somewhat better on midodrine and LDN
- Condition
- ME/CFS
- At worst
- Moderate (mostly housebound)
- Ill before improving or writing
- Not stated
- Last post
- Jul 2026
In their words
- At worst: Moderate
using my wheelchair in public
In context ↗ - Now: Somewhat better
Midodrine has helped the most out of them and has helped my ME a significant amount
In context ↗
Read from 4 of their posts and comments; links to the 4 this page draws on
Summary
They reported ME/CFS with comorbid MCAS and dysautonomia and used a wheelchair to get out, saying it let them do more than usual. They mentioned having surgery. Cromolyn and Xolair helped their MCAS most, midodrine helped most of their dysautonomia medications and significantly helped their ME, and LDN was helping before reaching the goal dose. They still mostly used a custom manual wheelchair and hoped a power assist would let them do more.
Ask Miruvor AI
What they tried
What they credit
Also tried
Their words about each treatment
- surgery · Not said
I had surgery :/
In context ↗ - Cromolyn sodium · Helped
Cromolyn sodium, xolair, Zyrtec, and famotadine helped my MCAS, but mostly the first two.
In context ↗ - LDN · Helped
I’m also on LDN and I think it’s helping my ME, but I haven’t gotten up to my goal dose yet.
In context ↗ - metoprolol · Not said
I’m also on metoprolol, midodrine, and ivabradine for dysautonomia.
In context ↗ - midodrine · Helped a lot
Midodrine has helped the most out of them and has helped my ME a significant amount, but that’s probably because I have comorbid dysautonomia.
In context ↗
Approaches: POTS medication
Their path
How ill they were on the ME/CFS severity scale, estimated from what they describe at each point, in the order they describe; they don’t give enough times to place each step. Hover or tap a point. Dates are when they posted. What the levels mean.
Show as a table
| When | What happened | Where they were | After |
|---|---|---|---|
| 2025-09-03 | using a wheelchair in public made more activity possibleI’m able to do more than I normally would be able toIn context ↗ | Moderate | |
| 2026-06-04 | surgery triggered a permanent worseningI had surgery :/In context ↗ | Moderate | |
| 2026-06-29 | medications helped MCAS, ME and dysautonomiaMidodrine has helped the most out of them and has helped my ME a significant amountIn context ↗ | Moderate | Midodrine |
| 2026-07-25 | mostly uses a custom manual wheelchair and a power chair; hopes power assist will let them do moreI mostly use a custom manual chairIn context ↗ | Moderate |
Symptoms mentioned
Their words about their symptoms
- POTS & dysautonomia
I have comorbid dysautonomia
In context ↗
Ask Miruvor AI
Similar stories
-
Mostly housebound with ME/CFS, now a little better on Klonopin and low-dose naltrexone
Joseph, 47, in Los Angeles, developed ME/CFS in January 2024, about 18 days after a second COVID infection. He declined from mild to the bad end of moderate over six months, becoming mostly housebound. Klonopin, low-dose naltrexone, midodrine and propranolol…
-
Almost bedridden with ME/CFS, now much better after a specialist regimen and pacing
A California woman infected with COVID in March 2020 was sick six months, partly recovered, then relapsed and was almost bedridden by early 2023, unable to drive and sensitive to light and noise. An out-of-pocket ME/CFS specialist regimen of LDN, Abilify,…
-
ME/CFS after COVID, more disabled by overwork, now somewhat better with pacing, wheelchair
After COVID-19 in 2020 she was still teaching theatre 20-30 hours a week; overworking for 8-10 weeks in summer 2024 left her more disabled, never back to baseline, now working four hours a week and using a wheelchair. Pacing, rest breaks and a wheelchair…
-
Bedbound with severe ME/CFS, now moving toward moderate with pacing and LDN
Ill with ME/CFS since a viral infection at age 8 in 2012, they fluctuated between mild and moderate/severe for over a decade. A virus in early 2025 dropped them from near remission to severe and bedbound, with worse POTS and suspected MCAS. Low-dose…